| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| PTEN Phosphohydrolase | 15 | 2015 | 73 | 3.230 |
Why?
|
| Tumor Suppressor Proteins | 8 | 2015 | 176 | 1.910 |
Why?
|
| Glioblastoma | 10 | 2016 | 131 | 1.850 |
Why?
|
| Brain Neoplasms | 12 | 2016 | 232 | 1.840 |
Why?
|
| Phosphoric Monoester Hydrolases | 6 | 2006 | 37 | 1.140 |
Why?
|
| Dacarbazine | 4 | 2016 | 18 | 1.070 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 3 | 2013 | 14 | 0.800 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 290 | 0.790 |
Why?
|
| Glioma | 5 | 2010 | 89 | 0.760 |
Why?
|
| Cell Membrane | 4 | 2015 | 459 | 0.660 |
Why?
|
| Antineoplastic Agents, Alkylating | 3 | 2014 | 25 | 0.620 |
Why?
|
| Lipid Bilayers | 2 | 2015 | 47 | 0.590 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 33 | 0.580 |
Why?
|
| ErbB Receptors | 2 | 2008 | 96 | 0.550 |
Why?
|
| Cell Line, Tumor | 11 | 2016 | 1256 | 0.540 |
Why?
|
| Biophysical Phenomena | 1 | 2015 | 19 | 0.540 |
Why?
|
| Phosphatidylinositol Phosphates | 3 | 2015 | 38 | 0.460 |
Why?
|
| Biomarkers, Tumor | 3 | 2009 | 398 | 0.400 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2010 | 60 | 0.380 |
Why?
|
| Phosphatidylinositols | 5 | 2022 | 43 | 0.380 |
Why?
|
| Mice, Nude | 5 | 2016 | 216 | 0.370 |
Why?
|
| Signal Transduction | 6 | 2014 | 2709 | 0.360 |
Why?
|
| Mutation | 5 | 2012 | 2142 | 0.360 |
Why?
|
| Membrane Proteins | 4 | 2013 | 753 | 0.350 |
Why?
|
| Animals | 22 | 2016 | 17887 | 0.350 |
Why?
|
| Chromosomal Instability | 1 | 2008 | 21 | 0.340 |
Why?
|
| Epidermal Growth Factor | 4 | 2022 | 51 | 0.340 |
Why?
|
| Autistic Disorder | 1 | 2010 | 154 | 0.330 |
Why?
|
| Neoplastic Stem Cells | 1 | 2009 | 187 | 0.330 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2016 | 164 | 0.320 |
Why?
|
| Protein Binding | 7 | 2015 | 1474 | 0.320 |
Why?
|
| Stem Cells | 3 | 2004 | 241 | 0.310 |
Why?
|
| Phosphorylation | 6 | 2015 | 789 | 0.310 |
Why?
|
| Mice | 15 | 2016 | 9258 | 0.310 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2014 | 254 | 0.290 |
Why?
|
| Gene Expression Profiling | 3 | 2010 | 646 | 0.280 |
Why?
|
| Cell Nucleus | 2 | 2008 | 566 | 0.280 |
Why?
|
| Neuropeptides | 1 | 2005 | 73 | 0.270 |
Why?
|
| Humans | 26 | 2016 | 50800 | 0.270 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2005 | 106 | 0.260 |
Why?
|
| Cell Proliferation | 5 | 2013 | 894 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2015 | 82 | 0.250 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2004 | 73 | 0.240 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2015 | 161 | 0.230 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2003 | 7 | 0.230 |
Why?
|
| Receptor, trkA | 1 | 2003 | 3 | 0.230 |
Why?
|
| Schizosaccharomyces | 1 | 2004 | 103 | 0.230 |
Why?
|
| Drug Synergism | 1 | 2003 | 118 | 0.230 |
Why?
|
| Talin | 1 | 2022 | 3 | 0.220 |
Why?
|
| Neuroblastoma | 1 | 2003 | 79 | 0.220 |
Why?
|
| Apoptosis | 6 | 2016 | 975 | 0.210 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2003 | 193 | 0.200 |
Why?
|
| Neurons | 2 | 2003 | 755 | 0.200 |
Why?
|
| Microscopy, Fluorescence | 3 | 2008 | 371 | 0.200 |
Why?
|
| Blotting, Western | 3 | 2008 | 535 | 0.190 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2010 | 451 | 0.190 |
Why?
|
| Cell Culture Techniques | 2 | 2010 | 169 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 3 | 2010 | 397 | 0.170 |
Why?
|
| Intermediate Filament Proteins | 3 | 2008 | 16 | 0.170 |
Why?
|
| Aniline Compounds | 2 | 2014 | 27 | 0.160 |
Why?
|
| Carrier Proteins | 1 | 2003 | 660 | 0.160 |
Why?
|
| Cell Differentiation | 5 | 2009 | 1232 | 0.160 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2009 | 187 | 0.160 |
Why?
|
| Recombinant Proteins | 4 | 2015 | 631 | 0.160 |
Why?
|
| Antineoplastic Agents | 3 | 2010 | 526 | 0.150 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 2 | 2014 | 19 | 0.150 |
Why?
|
| DNA Primers | 4 | 2011 | 276 | 0.150 |
Why?
|
| Hydroxyquinolines | 1 | 2016 | 3 | 0.150 |
Why?
|
| Cell Survival | 2 | 2013 | 520 | 0.150 |
Why?
|
| bcl-X Protein | 1 | 2015 | 15 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 3 | 2008 | 392 | 0.140 |
Why?
|
| Protein Conformation | 3 | 2009 | 720 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 5 | 2014 | 2908 | 0.140 |
Why?
|
| Endopeptidases | 1 | 2015 | 57 | 0.130 |
Why?
|
| Heterocyclic Compounds, 2-Ring | 1 | 2014 | 1 | 0.130 |
Why?
|
| Molecular Docking Simulation | 1 | 2015 | 74 | 0.130 |
Why?
|
| Codon, Initiator | 1 | 2014 | 10 | 0.130 |
Why?
|
| DNA Repair | 1 | 2016 | 209 | 0.130 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 139 | 0.130 |
Why?
|
| bcl-Associated Death Protein | 1 | 2014 | 8 | 0.130 |
Why?
|
| Phosphatidylserines | 2 | 2012 | 17 | 0.130 |
Why?
|
| Databases, Protein | 1 | 2014 | 43 | 0.130 |
Why?
|
| Membrane Fluidity | 1 | 2014 | 13 | 0.130 |
Why?
|
| RNA, Messenger | 3 | 2010 | 1366 | 0.120 |
Why?
|
| Transfection | 4 | 2015 | 612 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 722 | 0.120 |
Why?
|
| Nestin | 3 | 2008 | 12 | 0.120 |
Why?
|
| Benzenesulfonates | 2 | 2010 | 15 | 0.120 |
Why?
|
| Spectrophotometry, Infrared | 2 | 2010 | 27 | 0.120 |
Why?
|
| Amino Acids | 1 | 2014 | 130 | 0.120 |
Why?
|
| Models, Biological | 2 | 2009 | 1097 | 0.120 |
Why?
|
| DNA, Complementary | 2 | 2010 | 158 | 0.120 |
Why?
|
| Lipid Metabolism | 2 | 2006 | 193 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 615 | 0.120 |
Why?
|
| Pyridines | 2 | 2010 | 84 | 0.110 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2011 | 64 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 364 | 0.110 |
Why?
|
| Cholesterol | 1 | 2014 | 255 | 0.110 |
Why?
|
| Cell Lineage | 3 | 2009 | 244 | 0.110 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 104 | 0.110 |
Why?
|
| Microscopy, Confocal | 2 | 2010 | 208 | 0.110 |
Why?
|
| Glycine | 1 | 2011 | 40 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 2 | 2010 | 313 | 0.100 |
Why?
|
| Cell Division | 2 | 2010 | 388 | 0.100 |
Why?
|
| Ethylnitrosourea | 3 | 2006 | 6 | 0.100 |
Why?
|
| Carmustine | 1 | 2010 | 6 | 0.100 |
Why?
|
| Mitochondria | 2 | 2011 | 303 | 0.100 |
Why?
|
| Immunohistochemistry | 4 | 2006 | 796 | 0.100 |
Why?
|
| Membrane Lipids | 1 | 2010 | 22 | 0.100 |
Why?
|
| Spheroids, Cellular | 1 | 2010 | 25 | 0.100 |
Why?
|
| Activating Transcription Factors | 1 | 2010 | 10 | 0.100 |
Why?
|
| Unfolded Protein Response | 1 | 2011 | 50 | 0.100 |
Why?
|
| Dipeptides | 1 | 2010 | 54 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 42 | 0.100 |
Why?
|
| Cell Adhesion | 1 | 2010 | 215 | 0.090 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 208 | 0.090 |
Why?
|
| Exons | 1 | 2010 | 176 | 0.090 |
Why?
|
| Receptors, Notch | 1 | 2010 | 101 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 238 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2011 | 1998 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2014 | 150 | 0.090 |
Why?
|
| Culture Media | 1 | 2009 | 75 | 0.090 |
Why?
|
| Cell Death | 1 | 2010 | 251 | 0.090 |
Why?
|
| Brain | 2 | 2008 | 1193 | 0.090 |
Why?
|
| Radiation, Ionizing | 1 | 2008 | 16 | 0.090 |
Why?
|
| Karyotyping | 1 | 2008 | 40 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 451 | 0.090 |
Why?
|
| Retroviridae | 1 | 2008 | 68 | 0.080 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 94 | 0.080 |
Why?
|
| Integrases | 1 | 2008 | 34 | 0.080 |
Why?
|
| Rats | 4 | 2006 | 1675 | 0.080 |
Why?
|
| Centrosome | 1 | 2008 | 66 | 0.080 |
Why?
|
| Protein Folding | 2 | 2015 | 237 | 0.080 |
Why?
|
| Time Factors | 3 | 2006 | 3163 | 0.080 |
Why?
|
| Forecasting | 1 | 2007 | 192 | 0.080 |
Why?
|
| Prognosis | 1 | 2010 | 1271 | 0.070 |
Why?
|
| Sialoglycoproteins | 1 | 2006 | 17 | 0.070 |
Why?
|
| Pregnancy, Animal | 1 | 2006 | 10 | 0.070 |
Why?
|
| Dentate Gyrus | 1 | 2005 | 9 | 0.070 |
Why?
|
| Male | 4 | 2016 | 23363 | 0.070 |
Why?
|
| Astrocytes | 1 | 2006 | 95 | 0.070 |
Why?
|
| Diffusion | 1 | 2005 | 71 | 0.070 |
Why?
|
| Blotting, Northern | 1 | 2005 | 133 | 0.070 |
Why?
|
| Molecular Weight | 1 | 2005 | 177 | 0.070 |
Why?
|
| Inflammation | 1 | 2011 | 999 | 0.070 |
Why?
|
| Cerebral Ventricles | 1 | 2005 | 26 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 1 | 2005 | 200 | 0.070 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2005 | 18 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2005 | 50 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2010 | 3966 | 0.060 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2004 | 43 | 0.060 |
Why?
|
| Corpus Striatum | 1 | 2005 | 84 | 0.060 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2004 | 13 | 0.060 |
Why?
|
| Microtubules | 1 | 2005 | 202 | 0.060 |
Why?
|
| Protein Transport | 1 | 2005 | 371 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2008 | 1889 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 28 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2004 | 1104 | 0.060 |
Why?
|
| Cell Movement | 1 | 2005 | 390 | 0.060 |
Why?
|
| Nervous System | 1 | 2004 | 67 | 0.060 |
Why?
|
| Allosteric Site | 1 | 2003 | 30 | 0.060 |
Why?
|
| Ions | 1 | 2003 | 49 | 0.060 |
Why?
|
| Blastocyst | 1 | 2004 | 71 | 0.060 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2003 | 2 | 0.060 |
Why?
|
| Nerve Growth Factor | 1 | 2003 | 4 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2003 | 8 | 0.060 |
Why?
|
| Neurites | 1 | 2003 | 21 | 0.060 |
Why?
|
| PC12 Cells | 1 | 2003 | 22 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2003 | 70 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2003 | 129 | 0.060 |
Why?
|
| Antibodies, Blocking | 1 | 2003 | 35 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 43 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 150 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2003 | 169 | 0.060 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2003 | 37 | 0.060 |
Why?
|
| Phosphates | 1 | 2003 | 83 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2003 | 325 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 265 | 0.060 |
Why?
|
| Caspase 1 | 1 | 2003 | 103 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2003 | 96 | 0.060 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2022 | 3 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2003 | 167 | 0.050 |
Why?
|
| Cell Separation | 1 | 2002 | 132 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 278 | 0.050 |
Why?
|
| Caspases | 1 | 2003 | 150 | 0.050 |
Why?
|
| Kinetics | 1 | 2003 | 697 | 0.050 |
Why?
|
| Binding Sites | 2 | 2015 | 823 | 0.050 |
Why?
|
| Neoplasms | 1 | 2011 | 1087 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 281 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2003 | 631 | 0.050 |
Why?
|
| Niacinamide | 2 | 2010 | 24 | 0.050 |
Why?
|
| Phenylurea Compounds | 2 | 2010 | 26 | 0.050 |
Why?
|
| Gene Expression | 2 | 2015 | 739 | 0.050 |
Why?
|
| Neoplasm Transplantation | 2 | 2010 | 141 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 408 | 0.050 |
Why?
|
| Female | 7 | 2010 | 26652 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2006 | 504 | 0.050 |
Why?
|
| Cell Line | 2 | 2015 | 1922 | 0.040 |
Why?
|
| Autophagy | 2 | 2010 | 182 | 0.040 |
Why?
|
| Pregnancy | 4 | 2006 | 2158 | 0.040 |
Why?
|
| Scattering, Small Angle | 1 | 2015 | 12 | 0.040 |
Why?
|
| X-Ray Diffraction | 1 | 2015 | 54 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2015 | 13 | 0.030 |
Why?
|
| Base Sequence | 2 | 2011 | 1244 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 83 | 0.030 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2014 | 7 | 0.030 |
Why?
|
| DNA Modification Methylases | 1 | 2014 | 13 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 41 | 0.030 |
Why?
|
| DNA Repair Enzymes | 1 | 2014 | 26 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2015 | 234 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2015 | 153 | 0.030 |
Why?
|
| Indazoles | 1 | 2014 | 7 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 426 | 0.030 |
Why?
|
| Unilamellar Liposomes | 1 | 2014 | 8 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 394 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2015 | 353 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2015 | 488 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2014 | 115 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2006 | 156 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2014 | 114 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2014 | 277 | 0.030 |
Why?
|
| Temperature | 1 | 2014 | 281 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2014 | 362 | 0.030 |
Why?
|
| DNA Damage | 1 | 2014 | 273 | 0.030 |
Why?
|
| Neutrons | 1 | 2012 | 1 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2012 | 32 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 1779 | 0.030 |
Why?
|
| Guanidines | 1 | 2011 | 15 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2011 | 25 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 16 | 0.030 |
Why?
|
| Lactams, Macrocyclic | 1 | 2011 | 24 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 344 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 181 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2015 | 616 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 1498 | 0.020 |
Why?
|
| Cyclophilins | 1 | 2010 | 11 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2010 | 59 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 185 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 190 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 115 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 137 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2010 | 102 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2011 | 172 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 485 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2011 | 424 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2010 | 319 | 0.020 |
Why?
|
| Tryptophan | 1 | 2008 | 48 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 575 | 0.020 |
Why?
|
| Osteopontin | 1 | 2006 | 18 | 0.020 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2005 | 13 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 797 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 218 | 0.020 |
Why?
|
| Gliosis | 1 | 2004 | 18 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2004 | 28 | 0.020 |
Why?
|
| Carcinogens | 1 | 2004 | 35 | 0.020 |
Why?
|
| Transplantation Chimera | 1 | 2004 | 34 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2004 | 108 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 464 | 0.010 |
Why?
|
| Heterozygote | 1 | 2004 | 156 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2004 | 218 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 744 | 0.010 |
Why?
|
| Antimetabolites | 1 | 2002 | 15 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 37 | 0.010 |
Why?
|
| Clone Cells | 1 | 2002 | 101 | 0.010 |
Why?
|
| Brain Injuries | 1 | 2004 | 129 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 834 | 0.010 |
Why?
|
| Biomarkers | 1 | 2002 | 1003 | 0.010 |
Why?
|
| Aged | 1 | 2010 | 11017 | 0.010 |
Why?
|
| Middle Aged | 1 | 2010 | 13539 | 0.010 |
Why?
|
| Adult | 1 | 2010 | 13437 | 0.010 |
Why?
|